Cerus Corp.
(NASDAQ : CERS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 1.34%83.030.8%$1177.13m
MDTMedtronic Plc 2.87%97.170.6%$986.22m
TMOThermo Fisher Scientific, Inc. -0.42%295.331.0%$887.82m
ISRGIntuitive Surgical, Inc. 3.10%505.172.4%$741.43m
DHRDanaher Corp. 1.17%139.920.7%$711.93m
BDXBecton, Dickinson & Co. 2.16%242.671.1%$671.00m
SYKStryker Corp. 3.17%171.041.3%$614.54m
BSXBoston Scientific Corp. 3.18%34.761.1%$532.18m
EWEdwards Lifesciences Corp. 2.47%199.541.2%$439.21m
DXCMDexCom, Inc. 3.16%258.628.2%$402.66m
BAXBaxter International, Inc. 1.44%83.701.8%$373.74m
INOInovio Pharmaceuticals, Inc. -0.97%8.196.8%$299.58m
ZBHZimmer Biomet Holdings, Inc. 5.10%107.111.7%$293.60m
ALGNAlign Technology, Inc. 2.70%179.276.4%$270.54m
IDXXIDEXX Laboratories, Inc. -0.03%251.663.8%$265.06m

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.